indirubin has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, R; Hirayama, A; Kasahara, T; Otani, S; Suzuki, K; Watanabe, H; Watanabe, Y | 1 |
1 other study(ies) available for indirubin and n-formylmethionine leucyl-phenylalanine
Article | Year |
---|---|
Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells.
Topics: CD18 Antigens; Cell Differentiation; Chemotaxis; Cyclin-Dependent Kinases; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; HL-60 Cells; Humans; Image Processing, Computer-Assisted; Immunoblotting; Indoles; Interleukin-8; Leukemia, Myeloid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphorylation; Receptors, Granulocyte Colony-Stimulating Factor; Receptors, Interleukin-8A; Retinoblastoma Protein; Stimulation, Chemical; Superoxides | 2005 |